UROGEN PHARMA LTD (URGN) Stock Analyst Earnings Estimates
NASDAQ:URGN - Nasdaq - IL0011407140 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 48.04M 307.12% | 64.36M 33.97% | 82.713M 28.52% | 92.776M 12.17% | 133.81M 44.23% | 280.6M 109.70% | 503.96M 79.60% | 591.45M 17.36% | 925.53M 56.48% | 1.224B 32.25% | 1.508B 23.20% | 1.651B 9.48% | |
| EBITDA YoY % growth | -91.46M 27.60% | -78.12M 14.59% | -64.734M 17.14% | -96.985M -49.82% | -106.634M -9.95% | -32.613M 69.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -92.29M 27.18% | -79.04M 14.36% | -65.536M 17.09% | -95.172M -45.22% | -89.641M 5.81% | 29.806M 133.25% | 255.85M 758.38% | 344.26M 34.56% | 686.61M 99.45% | 959.81M 39.79% | 1.198B 24.82% | 1.31B 9.35% | |
| Operating Margin | -192.11% | -122.81% | -79.23% | -102.58% | -66.99% | 10.62% | 50.77% | 58.21% | 74.19% | 78.42% | 79.44% | 79.35% | |
| EPS YoY % growth | -4.96 16.22% | -4.78 3.57% | -3.73 22.02% | -3.22 13.77% | -2.86 11.05% | -0.43 84.81% | 2.48 670.42% | 3.87 56.24% | 6.12 58.03% | 8.18 33.67% | 9.65 17.96% | 9.84 1.96% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.76 -6.01% | -0.93 3.68% | -0.93 -2.00% | -0.73 -33.53% | -0.49 36.39% |
| Revenue Q2Q % growth | 26.188M 11.30% | 21.571M 14.86% | 26.957M 23.38% | 37.386M 48.33% | 52.612M 100.90% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.87M -63.39% | -30.539M -18.64% | -30.966M -19.84% | -22.451M -27.96% | -10.204M 57.25% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.55 19.12% | -0.83 | 0.28 | 34.01% |
| Q2 2024 Q2Q % growth | -0.91 11.65% | -0.85 | -0.06 | -7.23% |
| Q1 2024 Q2Q % growth | -0.97 25.38% | -0.88 | -0.09 | -9.81% |
| Q4 2023 Q2Q % growth | -0.72 40.98% | -0.69 | -0.03 | -3.81% |
| Q3 2023 Q2Q % growth | -0.68 39.98% | -0.86 | 0.18 | 21.20% |
| Q2 2023 Q2Q % growth | -1.03 12.71% | -1.16 | 0.13 | 11.11% |
| Q1 2023 Q2Q % growth | -1.30 -4.00% | -1.36 | 0.06 | 4.17% |
| Q4 2022 Q2Q % growth | -1.22 3.94% | -1.09 | -0.13 | -11.44% |
| Q3 2022 Q2Q % growth | -1.13 16.07% | -1.18 | 0.05 | 3.97% |
| Q2 2022 Q2Q % growth | -1.18 -0.85% | -1.30 | 0.12 | 9.27% |
| Q1 2022 Q2Q % growth | -1.25 -6.84% | -1.36 | 0.11 | 8.09% |
| Q4 2021 Q2Q % growth | -1.27 7.97% | -1.20 | -0.07 | -5.97% |
| Q3 2021 Q2Q % growth | -1.35 -3.05% | -1.32 | -0.03 | -2.47% |
| Q2 2021 Q2Q % growth | -1.17 18.75% | -1.15 | -0.02 | -1.87% |
| Q1 2021 Q2Q % growth | -1.17 34.64% | -1.32 | 0.15 | 11.42% |
| Q4 2020 Q2Q % growth | -1.38 25.81% | -1.40 | 0.02 | 1.34% |
| Q3 2020 Q2Q % growth | -1.31 -23.58% | -1.52 | 0.21 | 14.09% |
| Q2 2020 Q2Q % growth | -1.44 -33.33% | -1.61 | 0.17 | 10.77% |
| Q1 2020 Q2Q % growth | -1.79 -61.26% | -1.65 | -0.14 | -8.62% |
| Q4 2019 Q2Q % growth | -1.86 | -1.73 | -0.13 | -7.34% |
| Q3 2019 Q2Q % growth | -1.06 | -1.31 | 0.25 | 19.28% |
| Q2 2019 Q2Q % growth | -1.08 | -1.24 | 0.16 | 13.13% |
| Q1 2019 Q2Q % growth | -1.11 | -1.16 | 0.05 | 4.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 25.204M 20.87% | 24.688M | 516K | 2.09% |
| Q2 2024 Q2Q % growth | 21.848M 3.35% | 24.442M | -2.594M | -10.61% |
| Q1 2024 Q2Q % growth | 18.781M 9.24% | 21.809M | -3.028M | -13.88% |
| Q4 2023 Q2Q % growth | 23.53M 30.07% | 23.02M | 510K | 2.22% |
| Q3 2023 Q2Q % growth | 20.852M 29.52% | 20.43M | 422K | 2.07% |
| Q2 2023 Q2Q % growth | 21.139M 27.34% | 20.523M | 616K | 3.00% |
| Q1 2023 Q2Q % growth | 17.192M 26.78% | 17.525M | -333K | -1.90% |
| Q4 2022 Q2Q % growth | 18.09M 11.87% | 18.882M | -792K | -4.19% |
| Q3 2022 Q2Q % growth | 16.1M 41.85% | 20.549M | -4.449M | -21.65% |
| Q2 2022 Q2Q % growth | 16.6M 27.40% | 17.576M | -976K | -5.55% |
| Q1 2022 Q2Q % growth | 13.56M 81.04% | 15.482M | -1.922M | -12.41% |
| Q4 2021 Q2Q % growth | 16.17M 102.89% | 16.822M | -652K | -3.88% |
| Q3 2021 Q2Q % growth | 11.35M 228.03% | 15.728M | -4.378M | -27.84% |
| Q2 2021 Q2Q % growth | 13.03M 3,421.62% | 11.955M | 1.075M | 8.99% |
| Q1 2021 Q2Q % growth | 7.49M | 9.234M | -1.744M | -18.89% |
| Q4 2020 Q2Q % growth | 7.97M | 7.72M | 250K | 3.24% |
| Q3 2020 Q2Q % growth | 3.46M | 3.405M | 55K | 1.62% |
| Q2 2020 Q2Q % growth | 370K 1,750.00% | 264.517K | 105.483K | 39.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4.14% | 0.6% | -2.24% | 3.65% |
| Revenue | -1.76% | -5.33% | -1.08% | -1.98% |